Repligen

Repligen Free Cash Flow

The Free Cash Flow (FCF) of Repligen (RGEN) as of Oct 24, 2026 is 93.90 M USD. In the previous year, Free Cash Flow (FCF) was 142.49 M USD — a change of -34.10% (lower).

Free Cash Flow

93.90 MUSD

YoY

-34.10%

Last updated:

Free Cash Flow (FCF) of Repligen is 2025 93.90 M USD. Free Cash Flow (FCF) of Repligen was 2024 142.49 M USD. It decreases by -34.10% lower compared to the previous year.

The Repligen Free Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Free Cash Flow
Date
Free Cash Flow
Jan 1, 2018
18.73 M USD
Jan 1, 2019
44.06 M USD
Jan 1, 2020
36.28 M USD
Jan 1, 2021
51.93 M USD
Jan 1, 2022
38.74 M USD
Jan 1, 2023
74.93 M USD
Jan 1, 2024
142.49 M USD
Jan 1, 2025
93.90 M USD
The Repligen Free Cash Flow history
YEARFree Cash FlowYoY
93.90 MUSD-34.10%
142.49 MUSD+90.16%
74.93 MUSD+93.43%
38.74 MUSD-25.40%
51.93 MUSD+43.12%
36.28 MUSD-17.66%
44.06 MUSD+135.21%
18.73 MUSD+56.15%
12.00 MUSD+275.38%
3.20 MUSD-74.28%
12.43 MUSD-2.92%
12.80 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Repligen Stock analysis

What does Repligen do? Repligen Corp is an American company that was founded in 1981 and is headquartered in Waltham, Massachusetts. The company is a leading provider of products for the biopharmaceutical industry. It offers a wide range of innovative products and services that contribute to the acceleration and improvement of the development of biological drugs. The history of Repligen Corp begins in the 1980s when the company was originally founded to produce human proteins for medical purposes. Over the years, the company expanded its business and focused on the production of purification solutions for the biopharmaceutical industry. Today, Repligen is an established company in this field and serves customers around the world. Business model: Repligen Corp is a leading provider of products and services for the biopharmaceutical industry. The company focuses on the development and manufacturing of products for the purification of proteins and antibodies. These products are used by biotech and pharmaceutical customers to improve the effectiveness and safety of their products in the clinical development process. Repligen Corp is generally able to achieve good prices for its products as they are high-quality products for a high-priced industry. The company is also interested in introducing new products to the market and expanding its customer base. Various divisions: Repligen Corp offers a wide range of innovative products and services that contribute to the acceleration and improvement of the development of biological drugs. The company is divided into various divisions, including: 1. Chromaflow: Repligen's Chromaflow products offer a wide range of purification solutions for proteins and antibodies used in the biopharmaceutical industry. These products enable customers to test and develop their products faster and more effectively. 2. Protein A Adsorbent Resin: Repligen Corp offers a Protein A Adsorbent Resin used in biotherapy. It allows for highly efficient purification of therapeutics produced using Protein A. 3. Alternating Tangential Flow (ATF) Systems: Repligen's ATF system enables continuous cell culture of proteins and antibodies. This facilitates the production of biopharmaceutical products and shortens development time. 4. Process Analytical Technology (PAT): Repligen Corp's PAT system allows for accurate monitoring of the manufacturing process of biopharmaceutical products. It improves process control and reduces the risk of errors and failures. 5. Filtration products: Repligen's filtration products include disposable filters and microfiltration membranes. These products are used by customers in the biopharmaceutical industry for the purification of biological products. Products: Repligen Corp offers a wide range of innovative products and services to support the development of biological drugs. Here are some of the products offered by Repligen Corp: 1. Protein A Adsorbent Resin: This product is used in biotherapy and the biopharmaceutical industry to enable highly efficient purification of therapeutics produced using Protein A. 2. Alternating Tangential Flow (ATF) Systems: This system enables continuous cell culture of proteins and antibodies. It facilitates the production of biopharmaceutical products and shortens development time. 3. Chromaflow products: They offer a wide range of purification solutions for proteins and antibodies used in the biopharmaceutical industry. 4. PAT systems: Repligen Corp's PAT system allows for accurate monitoring of the manufacturing process of biopharmaceutical products. 5. Filtration products: Repligen's filtration products include disposable filters and membranes. These products are used by customers in the biopharmaceutical industry to purify biological products. In summary, Repligen Corp is an established company that focuses on the development and production of products and services for the biopharmaceutical industry. The company offers a wide range of innovative products that contribute to the acceleration and improvement of the development of biological drugs. With its long history and established reputation as a leading provider, Repligen Corp is a significant player in the biopharmaceutical industry. Repligen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Repligen stock

Free Cash Flow (FCF) of Repligen is 93.90 M USD in 2025.

Free Cash Flow (FCF) of Repligen changed from 142.49 M USD to 93.90 M USD, representing a -34.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow (FCF) Repligen since 2006 – with annual values, charts, and detailed analysis.

Free Cash Flow is the cash available after capital expenditures. It represents the cash a company can use for dividends, debt reduction, or reinvestment.

FCF = Operating Cash Flow - Capital Expenditures

Free Cash Flow (FCF)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Free Cash Flow (FCF)'s Repligen historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Repligen

All Key Metrics — Repligen